Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Curcumin Help Arteriovenous Fistula Maturation

Dedy Pratama, Hendro Sudjono Yuwono*, Rudi Supriyadi, Herry Herman

Department of Surgery, School of Medicine, Universitas Padjadjaran, Bandung, Indonesia

Abstract: Curcumin has many advantages, i.e., antioxidant, antiplatelet, anti-inflammatory, and antidiabetes. It applied for the maturation of arteriovenous fistula (AVF) in the diabetic end-stage renal disease of two diabetic patients. The administration of oral Curcumin examined the maturation on the 4th week and the 8th week. The results in both cases show maturity at the end of eight weeks without any complication.

Keywords: Curcumin, Arteriovenous fistula, maturation, diabetes mellitus type-2

Received May 28, 2020; Revised June 29, 2020; Accepted July 08, 2020

Citation: Dedy Pratama, Hendro Sudjono Yuwono, Rudi Supriyadi, Herry Herman, Curcumin Help Arteriovenous Fistula Maturation. American Journal of Medical Case Reports, 8 (10). 365-366. January 2020. doi:10.12691/ajmcr-8-10-12

1. Introduction

The successful operation of the arteriovenous shunt (AVF) is necessary to implement hemodialysis in patients with end-stage renal failure. AVF often experience disturbances in maturation so that it cannot function properly. AVF maturation means 600ml/minute blood flow, less than 6 mm below the skin, 6mm vein diameter, and ready for hemodialysis. The trouble is mainly by the formation of blood clots in anastomotic wounds that block blood flow. Various drugs have tried given to prevent and overcome the disorder. In this report, the results of the use of Curcumin will be presented. Curcumin is an antioxidant, antibacterial, anti-inflammatory, anti-clotting, which can prevent the onset of AVF dysfunction [1]. The use of Curcumin has proven to increase the maturation success of AVF as the two cases mentioned below.

Case no.1. Mr. M., a 60-year-old man with type 2 diabetes mellitus, a patient with late-stage kidney failure. No smoking. He must undergo hemodialysis every three days. He underwent surgery to make AVF (arterial-side to venous-end anastomosis) in the left cubital fossa. The day before the operation, he took Curcumin 2gram once a day, continued for 8 weeks. Before surgery, blood levels of sugar were checked when urea, creatinine, cholesterol, all showed normal levels except levels of urea, creatinine, leukocytes. The diameter of the cephalic vein is 3mm, and the diameter of the brachial artery is 5.1 mm. In this case, there were no signs of bleeding. The wound healed with maturation without any complications. In the 4th week, the blood vein flow was 972ml/minute, with the vein diameter 5.9 mm, and 6 mm below the skin. In the 8th week, the blood vein flow was 980ml/minute, with the vein diameter 6mm, and 6 mm below the skin.

Case no.2. Mrs. H., a 55-year-old woman, type 2 Diabetes mellitus sufferer, patients with late-stage kidney failure, undergo hemodialysis every three days. He underwent surgery to make AVF (arterial-side to venous-end anastomosis) in the left cubital fossa. Before surgery, she took 2 gram of oral Curcumin for 8 weeks. The diameter of the cephalic vein is 3mm, and the diameter of the brachial artery is 5 mm. In this case, there were no signs of bleeding. Before surgery, sugar blood levels checked when urea, creatinine, leukocytes, cholesterol. All levels normal except levels of urea and creatinine.

The wound healed with maturation without any complications.

In the 4th week, the blood vein flow was 875ml/minute, the vein diameter 6mm, 6 mm below the skin.

In the 8th week, the blood vein flow was 1204ml/minute, the vein diameter 6 mm, 6 mm below the skin.

Both patients do not smoke. The wound healed uneventfully.

The measurement was applying the portable ultrasonography of G.E. U.S.A LOGIQ e Pro Edition (2019).

Curcumin is a chemical compound in turmeric, administered orally in the shape of an oral pill (CURCUMIN optimized curcumin 500mg, Sabinsa Corporation, New Jersey USA). Side effects not found in both patients.

2. Discussion

In Indonesia, Curcuma longa is a food and drink for health that easily found in the market in the form of cooked food or the type of drinks in the form of herbs suitable for our bodies. That is Curcumin, as an active substance in the roots of Curcuma longa has the ability as a potent anti-inflammatory, is very popular and cheap. Still, no side effects have reported [2]. Curcumin has an antibacterial, anti-inflammatory, anti-clotting blood, antioxidant [1]. Some community groups also use Curcumin powder as an alternative to effective wound cover.

AVF surgery has performed on patients with end-stage chronic kidney failure for hemodialysis, resulting in about 5-15% causing failure (occluded by thrombus), so it does not mature. Research into the use of oral Curcumin and the relationship between AVF maturation has not conducted. In our experience, given the influence of Curcumin, which can prevent blood clots, the success of AVF expected to increase. As in the two cases above, it shows that Curcumin can improve maturity. In the second case, maturity occurs in the 8th week. It can also say to be a contribution of Curcumin.

Figure 1. Description of the position of the left brachial artery anastomosis and left Cephalic vein. Curcumin has the ability as antioxidant, anti-inflammatory, antiplatelet, antibacterial, anti-diabetes (ESRD, End-Stage Renal Disease. AVF, Arteriovenous fistula)

Curcumin's vast ability to heal wounds after anastomosis surgery is very beneficial in preventing failure and surgical complications. Curcumin has an antifibrotic via lowering associated inflammation factors and leading the manifestation of anti-inflammation factors [3]. There are reports of hemorrhage (postoperative hematoma) in a patient undergoing a continuous infusion of 3-5gram Curcumin per day with unclear indications [4]. The bleeding stops, and the hematoma subsides after the Curcumin infusion is stopped [4]. Alleged bleeding due to high doses. Both patients have diabetes, then the Curcumin with its anti-diabetic properties is a correct policy provided to the patients [5]. It administered orally every day and chronically.

Conclusion, the Curcumin is strictly correct for getting a better arteriovenous fistula maturation in diabetic end-stage renal disease.

Conflict of Interest

All authors have no conflicts of interest to declare.

References

[1]   | Sri Vasavi ReddyA, Suresh J, Hemant KS, Singh A. A review on Curcuma longa. Res J Pharm Tech. 2012; 5: 158-65.
[2]   | Ghosh SS, Gehr TWB, Ghosh S. Curcumin and Chronic Kidney Disease (CKD): Major Mode of Action through Stimulating Endogenous Intestinal Alkaline Phosphatase. Molecules. 2014, 19, 20139-20156.
[3]   | Sun X, Liu Y, Li C, Wang X, Zhu R, Liu C, et al. Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis. Hindawi BioMed Research International. 2017; Volume 2017, Article ID 2418671, pp.1-9.
[4]   | Monzon T, Valga F, Henriquez F. Curcumin intake in hemodialysis patients. Nefrologia. 2018; 38(6): 660-680.
[5]   | Kazazis C, Vallianou NG, Kollas A, Evangelopoulos A. Curcumin and Diabetes: Mechanism of action and anti-Diabetic properties. CURRENT TOPICS IN NUTRACEUTICAL RESEARCH. 2014; 12 (4, pp): 135-142.